Table 2.
APO | 2-PCPAa | InsP6b | |
---|---|---|---|
Post-equilibrium Apparent Parameters | |||
kcat,post (s−1) | 0.70 ± 0.03 | 0.52 ± 0.05 | 0.78 ± 0.18 |
KM,post (μM) | 33 ± 6 | 22 ± 4 | 12 ± 5 |
kcat,post/KM,post (s−1mM−1) | 21 ± 2 | 23 ± 3 | 70 ± 50 |
Unimolecular Exchange | |||
Keq(E) | 6.8 ± 2.3 | 5.5 ± 2.2 | 1.9 ± 2.1 |
kex(E) (s−1) | <10−7 | 0.0031 ± 0.0017 | 0.14 ± 0.17 |
Keq(ES) | 2,560 ± 1,620 | 280 ± 220 | 1,990 ± 1,600 |
kex(ES) (s−1) | 0.077 ± 0.042 | 0.0028 ± 0.0016 | 0.09 ± 0.07 |
The CoREST complex was pre-equilibrated with 0.1 mM 2-PCPA LSD1 inhibitor.
The CoREST complex was pre-equilibrated with 0.1 mM InsP6.